PMDA drug package insert
フロモックス錠75mg
PMDA Prescription drug · 塩野義製薬株式会社 · package insert Jan 28, 2026
Key facts
| Brand names | フロモックス錠75mg, フロモックス錠100mg |
|---|---|
| Nonproprietary names | セフカペン ピボキシル塩酸塩水和物 |
| Companies | 製造販売元／塩野義製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 経口用セフェム系抗生物質製剤 |
| Therapeutic category codes | 876132 |
| YJ codes | 6132016F1023, 6132016F2020 |
| Approval numbers | 20900AMZ00334000, 20900AMZ00335000 |
| Package insert edition | 第4版 |
| Package insert date | Jan 28, 2026 |
| PMDA document key | 340018_6132016F1023_1 |
| PMDA company code | 340018 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: